Health Care & Life Sciences » Medical Equipment & Supplies | Hemagen Diagnostics Inc.

Hemagen Diagnostics Inc. | Income Statement

Fiscal year is October-September. All values USD Thousands.
2008
2009
2010
2011
2012
Sales/Revenue
6,374.80
5,418.90
5,220.20
5,141.20
4,042.10
Cost of Goods Sold (COGS) incl. D&A
3,602.70
3,346.50
2,864.00
3,334.10
2,428.60
Gross Income
2,772.10
2,072.40
2,356.20
1,807.20
1,613.40
SG&A Expense
2,654.10
2,421.10
2,120.30
2,279.90
2,051.40
EBIT
118.00
348.70
235.90
472.70
437.90
Non Operating Income/Expense
13.60
43.70
29.60
2.90
0.20
Interest Expense
375.70
404.10
332.30
406.60
469.20
Pretax Income
244.00
709.10
66.70
876.30
907.30
Income Tax
129.30
20.80
89.60
4.10
-
Consolidated Net Income
373.40
729.90
156.30
880.50
907.30
Net Income
373.40
729.90
156.30
880.50
907.30
Net Income After Extraordinaries
1,173.90
651.80
156.30
880.50
907.30
Net Income Available to Common
373.40
808.10
156.30
880.50
907.30
EPS (Basic)
0.03
0.05
0.01
0.06
0.06
Basic Shares Outstanding
15,225.30
15,234.70
15,454.10
15,476.50
15,496.20
EPS (Diluted)
0.03
0.05
0.01
0.06
0.06
Diluted Shares Outstanding
15,229.80
15,234.70
15,454.10
15,476.50
15,496.20
EBITDA
225.60
192.00
399.90
286.90
273.70

About Hemagen Diagnostics

View Profile
Address
9033 Red Branch Road
Columbia Maryland 21045
United States
Employees -
Website http://www.hemagen.com
Updated 07/08/2019
Hemagen Diagnostics, Inc. is a biotechnology company. It develops, manufactures, and markets Food and Drug Administration cleared proprietary medical diagnostic test kits and components. Its product lines include Virgo, which consist of various diagnostic test kits that are used to aid in the diagnosis of certain autoimmune and infectious diseases, using ELISA, Immunoflourescence, and hemagglutination technology; and Analyst product line, an Food and Drug Administration-cleared Benchtop Clinical Chemistry Analyzer System, including consumables that are used to measure important constituents in human and animal blood.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.